Asthmatx Acquisition By Boston Scientific Is Source of Many Happy Returns

Boston Scientific's acquisition of Asthmatx marks a return of the company to the field of strategic buyers with the deal, and in picking Asthmatx, BSX is is reversing a decision it made two years when it sold off its strategic stake in the asthma-device company.

Boston Scientific Corp.'s acquisition of Asthmatx Inc. was the source of many happy returns, three to be exact. [See Deal] The deal marks Boston Scientific's return to the field of strategic buyers, and in picking asthma-device company Asthmatx, BSX returns to a company, the equity stake of which it sold off two years ago. Finally, venture capitalists were happy to see a different kind of return; payback for investing in the interventional pulmonology space.

The acquisition, which still needs shareholder approval, marks the first significant acquisition by the beleaguered device giant in five years...

More from Archive

More from In Vivo